TRIP4 and breast cancer: Moreover, Yoo et al have recently demonstrated that the ufmylated form of UFBP1 is a co-component of Ufl1 E3 ligase that promotes ufmylation of nuclear receptor co-activator ASC1, an event that is crucial for estrogen receptor signaling and breast cancer development [8].